FDA Inspection
KRS Global Biotechnology, IncKRS Global Biotechnology, Inc – FDA Inspection, Oct 23, 2017
Record Details
This FDA Inspection record concerns KRS Global Biotechnology, Inc, with an inspection on October 23, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5a8d42af-0af0-4dc1-a333-681c97ef4b8e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1029456
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of KRS Global Biotechnology, Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 31, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for KRS Global Biotechnology, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.